It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
INCR’s FA Score shows that 1 FA rating(s) are green whileSNDL’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
INCR’s TA Score shows that 5 TA indicator(s) are bullish while SNDL’s TA Score has 3 bullish TA indicator(s).
INCR (@Pharmaceuticals: Other) experienced а +4.46% price change this week, while SNDL (@Beverages: Alcoholic) price change was +2.34% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.08%. For the same industry, the average monthly price growth was +10.49%, and the average quarterly price growth was +31.12%.
The average weekly price growth across all stocks in the @Beverages: Alcoholic industry was -1.44%. For the same industry, the average monthly price growth was -1.64%, and the average quarterly price growth was -0.82%.
INCR is expected to report earnings on Aug 18, 2025.
SNDL is expected to report earnings on Aug 13, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Beverages: Alcoholic (-1.44% weekly)The alcoholic beverage market includes beer, wine, and spirits. From $230 billion in 2015, the industry has grown to around $250 billion by 2019. In recent years, alcoholic beverage makers have been looking to expand distribution and purchase channels, such as through online stores (e.g. e-commerce platform Drizly) and convenience stores. Anheuser-Busch In Bev and Diageo are major global alcoholic beverage companies, while U.S.-owned companies include Constellation Brands and Brown-Forman Corp. among several others.
INCR | SNDL | INCR / SNDL | |
Capitalization | 124M | 527M | 24% |
EBITDA | 25.8M | -99.15M | -26% |
Gain YTD | -0.792 | -26.816 | 3% |
P/E Ratio | 22.52 | 3.54 | 637% |
Revenue | 415M | 909M | 46% |
Total Cash | 103M | 202M | 51% |
Total Debt | 163M | 167M | 98% |
INCR | SNDL | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 5 | 8 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 57 Fair valued | 67 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 94 | 91 | |
PRICE GROWTH RATING 1..100 | 52 | 85 | |
P/E GROWTH RATING 1..100 | 4 | 91 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
INCR's Valuation (57) in the Servicestothe Health Industry industry is in the same range as SNDL (67) in the null industry. This means that INCR’s stock grew similarly to SNDL’s over the last 12 months.
INCR's Profit vs Risk Rating (100) in the Servicestothe Health Industry industry is in the same range as SNDL (100) in the null industry. This means that INCR’s stock grew similarly to SNDL’s over the last 12 months.
SNDL's SMR Rating (91) in the null industry is in the same range as INCR (94) in the Servicestothe Health Industry industry. This means that SNDL’s stock grew similarly to INCR’s over the last 12 months.
INCR's Price Growth Rating (52) in the Servicestothe Health Industry industry is somewhat better than the same rating for SNDL (85) in the null industry. This means that INCR’s stock grew somewhat faster than SNDL’s over the last 12 months.
INCR's P/E Growth Rating (4) in the Servicestothe Health Industry industry is significantly better than the same rating for SNDL (91) in the null industry. This means that INCR’s stock grew significantly faster than SNDL’s over the last 12 months.
INCR | SNDL | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 1 day ago82% | 1 day ago90% |
Momentum ODDS (%) | 1 day ago85% | 1 day ago80% |
MACD ODDS (%) | 1 day ago83% | 1 day ago81% |
TrendWeek ODDS (%) | 1 day ago78% | 1 day ago78% |
TrendMonth ODDS (%) | 1 day ago72% | 1 day ago84% |
Advances ODDS (%) | 4 days ago72% | 24 days ago73% |
Declines ODDS (%) | 1 day ago80% | 17 days ago87% |
BollingerBands ODDS (%) | 1 day ago78% | 1 day ago87% |
Aroon ODDS (%) | 1 day ago80% | 4 days ago84% |
A.I.dvisor tells us that INCR and TLRY have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INCR and TLRY's prices will move in lockstep.
Ticker / NAME | Correlation To INCR | 1D Price Change % | ||
---|---|---|---|---|
INCR | 100% | N/A | ||
TLRY - INCR | 29% Poorly correlated | +3.26% | ||
KMDA - INCR | 26% Poorly correlated | N/A | ||
SNDL - INCR | 25% Poorly correlated | N/A | ||
ACB - INCR | 24% Poorly correlated | +5.17% | ||
OGI - INCR | 24% Poorly correlated | +2.24% | ||
More |